Page 68 - Read Online

Anand et al. J Cancer Metastasis Treat 2019;5:6 I http://dx.doi.org/10.20517/2394-4722.2018.98 Page 13 of 14

DECLARATIONS
Acknowledgments
We thank Dr. Tayyaba Hasan (Massachusetts General Hospital) and Dr. Brian Pogue (Dartmouth Medical
Center) for their longstanding collaborations with us through an NIH Program Project that they co-direct.

Authors’ contributions
Conception and design, gather experimental data, analysis, interpretation and writing: Anand S
Gather experimental data: Yasinchak A, Bullock T, Govande M
Conception and design, analysis, interpretation, funding and writing: Maytin EV

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by P01CA084203 (Tayyaba Hasan and Edward Maytin) from the National Cancer
Institute, National Institutes of Health, USA; Velosano pilot award grant, Cleveland Clinic (Edward Maytin
and Sanjay Anand); and NIH shared instrument grant award S100D018205 (IVIS Spectrum) to Imaging
Core, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers
Prev 2016;25:16-27.
3. Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev
2017;26:444-57.
4. Weigelt B, Peterse JL, van ‘t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005;5:591-602.
5. Danish Breast Cancer Cooperative Group, Nielsen HM, Overgaard M, Grau C, Jensen AR, et al. Study of failure pattern among high-risk
breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the
Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 2006;24:2268-75.
6. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, et al. Locoregional radiation therapy in patients with high-risk breast cancer
receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005;97:116-26.
7. Hasan T, Ortel B, Solban N, Pogue BW. Photodynamic therapy of cancer. 7th edition. Hamilton, Ontario: BC Decker, Inc.; 2006. pp. 537-48.
8. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.
Chem Rev 2010;110:2795-838.
9. Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV. Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Letters
2012;326:8-16.
10. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical
experience. J Photochem Photobiol B 1990;6:143-8.
11. Marcus SL, Sobel RS, Golub AL, Carroll RL, Lundahl S, et al. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous
photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J Clin Laser Med Surg 1996;14:59-66.
12. Ahmad N, Mukhtar H. Mechanism of photodynamic therapy-induced cell death. Methods Enzymol 2000;319:342-58.